Colgate-Palmolive Company (CL) : Dillon Associates Inc reduced its stake in Colgate-Palmolive Company by 0.54% during the most recent quarter end. The investment management company now holds a total of 146,151 shares of Colgate-Palmolive Company which is valued at $10,496,565 after selling 795 shares in Colgate-Palmolive Company , the firm said in a disclosure report filed with the SEC on May 3, 2016.Colgate-Palmolive Company makes up approximately 4.93% of Dillon Associates Inc’s portfolio.
Other Hedge Funds, Including , Armbruster Capital Management reduced its stake in CL by selling 800 shares or 8.57% in the most recent quarter. The Hedge Fund company now holds 8,540 shares of CL which is valued at $613,343. Colgate-Palmolive Company makes up approx 0.42% of Armbruster Capital Management’s portfolio.Baltimore-washington Financial Advisors boosted its stake in CL in the latest quarter, The investment management firm added 8,659 additional shares and now holds a total of 68,215 shares of Colgate-Palmolive Company which is valued at $4,899,201. Colgate-Palmolive Company makes up approx 1.49% of Baltimore-washington Financial Advisors’s portfolio. Moisand Fitzgerald Tamayo sold out all of its stake in CL during the most recent quarter. The investment firm sold 45 shares of CL which is valued $3,191.Horan Capital Management reduced its stake in CL by selling 1,050 shares or 3.76% in the most recent quarter. The Hedge Fund company now holds 26,870 shares of CL which is valued at $1,855,642. Colgate-Palmolive Company makes up approx 0.51% of Horan Capital Management’s portfolio.Weybosset Research Management reduced its stake in CL by selling 880 shares or 1.24% in the most recent quarter. The Hedge Fund company now holds 69,916 shares of CL which is valued at $4,828,399. Colgate-Palmolive Company makes up approx 3.96% of Weybosset Research Management’s portfolio.
Colgate-Palmolive Company opened for trading at $71.86 and hit $72.245 on the upside on Tuesday, eventually ending the session at $72.2, with a gain of 0.61% or 0.44 points. The heightened volatility saw the trading volume jump to 27,10,879 shares. Company has a market cap of $64,476 M.
On the company’s financial health, Colgate-Palmolive Company reported $0.63 EPS for the quarter, based on the information available during the earnings call on Apr 28, 2016. Analyst had a consensus estimate of $0.63. The company had revenue of $3762.00 million for the quarter, compared to analysts expectations of $3760.63 million. The company’s revenue was down -7.6 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.66 EPS.
Many Wall Street Analysts have commented on Colgate-Palmolive Company. Colgate-Palmolive Company was Upgraded by Goldman to ” Neutral” on May 2, 2016. Company shares were Reiterated by UBS on Apr 29, 2016 to “Neutral”, Firm has raised the Price Target to $ 76 from a previous price target of $73 .Colgate-Palmolive Company was Downgraded by Sterne Agee CRT to ” Neutral” on Feb 26, 2016.
Colgate-Palmolive Company (Colgate) is a consumer products company whose products are marketed in more than 200 countries and territories throughout the world. The Company operates in two product segments: Oral Personal and Home Care and Pet Nutrition. The Oral Personal and Home Care product segment is operated through five geographic segments: North America Latin America Europe/South Pacific Asia and Africa/Eurasia. The Company’s oral care products include Colgate Total; Colgate Sensitive Pro-Relief; Colgate Max Fresh; Colgate Optic White and Colgate Luminous White toothpastes among others. The Company sells its personal care products under the Palmolive Protex and Softsoap brands. The Company through its Hill’s Pet Nutrition segment (Hill’s) manufactures pet nutrition products for dogs and cats.